🔬 Training Transformers to solve 95% failure rate of Cancer Trials — Ron Alfa & Daniel Bear, Noetik
DGX agentNoetik uses transformer neural networks and machine learning to improve cancer drug trial success rates, addressing the historically high failure rate (95%) in clinical development. The approach lever